Clinical Trial NCT03427060
Trial
Akari – AK585 CONSENT II (NCT03427060)
Clinical trial ID
NCT03427060
Drug name
Nomacopan/ Coversin
Company:
Akari
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
2
Current status
enolling by invitation
Start
05/2018
Substance
tick saliva protein
Research question
patients with resistanceto eculizumab
Delivery method of drug
s.c.
Frequency
2 x daily
Clinical trial locations
USA